4//SEC Filing
Chelsea Therapeutics International, Ltd. 4
Accession 0001181431-05-049299
CIK 0001333763operating
Filed
Aug 28, 8:00 PM ET
Accepted
Aug 29, 2:38 PM ET
Size
9.0 KB
Accession
0001181431-05-049299
Insider Transaction Report
Form 4
Riehle J Nick
Chief Financial Officer
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2005-08-25−14,663→ 44,020 totalExercise: $0.07Exp: 2014-07-01→ Common Stock (58,683 underlying) - Exercise/Conversion
Common Stock
2005-08-25$0.07/sh+14,663$1,000→ 14,663 total
Holdings
- 68,923
Stock Option (Right to Buy)
Exercise: $2.62Exp: 2015-01-10→ Common Stock (68,923 underlying)
Footnotes (2)
- [F1]Option vests in two equal annual installments beginning on July 1, 2005.
- [F2]Option vests in two equal annual installments beginning on January 10, 2006.
Documents
Issuer
Chelsea Therapeutics International, Ltd.
CIK 0001333763
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001333763
Filing Metadata
- Form type
- 4
- Filed
- Aug 28, 8:00 PM ET
- Accepted
- Aug 29, 2:38 PM ET
- Size
- 9.0 KB